Short-duration psychedelic therapy shows promise for major depression treatment

https://www.news-medical.net/news/20260217/Short-duration-psychedelic-therapy-shows-promise-for-major-depression-treatment.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=pharmacy_and_pharmacology_newsletter_27_february_2026 In a recent study published in the journal Nature Medicine, researchers evaluated the safety and efficacy of a short-acting psychedelic, dimethyltryptamine (DMT), in adults with major depressive disorder (MDD).